di{5-methylpyrazol-3-yl}pyridine) adopts a 1 : 1 high : low spin state population, and can be converted into different high-spin anhydrous phases by recrystallisation (phase 1 A ) or by thermal dehydration (phase 1 B ). Upon cooling in vacuo, the latter undergoes a thermal spinstate transition centred near T 1/2 ¼ 205 K. The transition has a thermal hysteresis width of 65 K in freshly prepared samples, although this gradually narrows to 37 K on repeated scanning. X-Ray powder diffraction measurements performed in vacuo show that 1 B , initially formed at 375 K, exhibits two consecutive crystallographic phase changes near 300 and 270 K, before undergoing a third phase change concomitant with its spin-state transition. None of these new phases is isostructural with 1 A , which itself undergoes a thermal spin-crossover on cooling without a change in crystal symmetry.
Two salts of [FeL2](2+) (L = 2,6-bis[5-methyl-1H-pyrazol-3-yl]pyridine) are isostructural under ambient conditions but show different thermal spin-crossover behaviour, involving a variety of crystallographic phase changes.
Dedicated to George Christou on the occasion of his 60 th birthday.
2
TOC EntryFour different complexes of the type shown, [Fe(L R ) 2 ] 2+ , have been prepared, with R = methyl, allyl, benzyl and isopropyl. All the compounds are high-spin in acetone solution and the solid state at room temperature and below, except for one salt of [Fe(L Me ) 2 ] 2+ which is predominantly low-spin at 150 K in the crystal. This contrasts with the parent complex (R = H), which exhibits thermal spin-crossover just below room temperature.
KeywordsIron; N-donor ligands; Crystal Structure; Magnetic Measurements; Spin-Crossover
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.